I'm LongbridgeAI, I can summarize articles.The Week
China Life (2628.HK) came under pressure this week. On Thursday the stock dropped 4%, and on Friday it hit a 52-week low. There was no major catalyst during the week, with the share price moving in a single-direction decline alongside the Hang Seng Index, which fell 5.65%. The latest quote shows the stock at HK$21.52, down from the previous close of HK$21.84. Valuation remains modest at around 6.9x P/E and 0.8x P/B.
Analyst Ratings
A total of 16 brokers cover the stock: 9 rate it buy, 5 rate it overweight, 1 neutral, and 1 sell. The consensus rating is buy, with a consensus target price of HK$35.86, about 66.6% above the current price. Target prices range from HK$14.27 to HK$44.51, showing a wide spread. The stock ranks second within its industry group of 11 companies.
The Week Ahead
The 2026 annual results are scheduled for 25 March 2027, so no direct earnings event is due in the near term. In the coming week, the focus will be on whether the Hang Seng Index stabilises and whether China Life can hold above its 52-week low.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
